Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid

Virology Journal

Volumn 12, Issue 1, 2015, Pages

  Zhang, Xiangmin ^a,b   Curtiss, Roy ^a,c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c University of Florida   (United States)

Author keywords

Influenza virus; Mouse RNA polymerase I promoter; Reverse genetics

Indexed keywords

DNA DIRECTED RNA POLYMERASE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; PLASMID VECTOR; VIRUS PROTEIN; VIRUS RNA; VIRUS SIALIDASE; LIVE VACCINE; VIRUS ANTIGEN;

ANIMAL CELL; ARTICLE; BHK CELL LINE; CHO CELL LINE; CONTROLLED STUDY; GENE CASSETTE; GENE IDENTIFICATION; GENETIC CODE; GENETIC TRANSFECTION; HA GENE; INFLUENZA VIRUS A; MDCK CELL LINE; NA GENE; NONHUMAN; PLASMID; REVERSE GENETICS; TISSUE CULTURE; VACCINE PRODUCTION; VIROGENESIS; VIRUS STRAIN; VIRUS TITRATION; ANIMAL; BIOSYNTHESIS; CRICETULUS; DOG; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; ORTHOMYXOVIRIDAE; PROCEDURES;

AVES; BACTERIA (MICROORGANISMS); CRICETINAE; CRICETULUS GRISEUS; INFLUENZA A VIRUS; MURINAE; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIGENS, VIRAL; CHO CELLS; CRICETULUS; DOGS; INFLUENZA VACCINES; MADIN DARBY CANINE KIDNEY CELLS; MICE; ORTHOMYXOVIRIDAE; PLASMIDS; REVERSE GENETICS; RNA POLYMERASE I; RNA, VIRAL; VACCINES, ATTENUATED;

EID: 84936761888     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-015-0321-5     Document Type: Article

References (50)

1. Noda T, Sagara H, Yen A, Takada A, Kida H, Cheng RH, et al. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature. 2006;439:490-2.
2. Murti KG, Webster RG, Jones IM. Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology. 1988;164:562-6.
3. Klumpp K, Ruigrok RW, Baudin F. Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure. EMBO J. 1997;16:1248-57.
4. Parvin JD, Palese P, Honda A, Ishihama A, Krystal M. Promoter analysis of influenza virus RNA polymerase. J Virol. 1989;63:5142-52.
5. Luytjes W, Krystal M, Enami M, Parvin JD, Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell. 1989;59:1107-13.
6. Neumann G, Zobel A, Hobom G. RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology. 1994;202:477-9.
7. Zobel A, Neumann G, Hobom G. RNA polymerase I catalysed transcription of insert viral cDNA. Nucleic Acids Res. 1993;21:3607-14.
8. Pleschka S, Jaskunas R, Engelhardt OG, Zurcher T, Palese P, Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J Virol. 1996;70:4188-92.
9. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A. 1999;96:9345-50.
10. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J Virol. 1999;73:9679-82.
11. Hoffmann E, Webster RG. Unidirectional RNA polymerase I-polymerase II transcription system for the generation of influenza A virus from eight plasmids. J Gen Virol. 2000;81:2843-7.
12. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A. 2000;97:6108-13.
13. Heix J, Grummt I. Species specificity of transcription by RNA polymerase I. Curr Opin Genet Dev. 1995;5:652-6.
14. Murakami S, Horimoto T, Yamada S, Kakugawa S, Goto H, Kawaoka Y. Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production. J Virol. 2008;82:1605-9.
15. Wang Z, Duke GM. Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells. Virol J. 2007;4:102.
16. Massin P, Rodrigues P, Marasescu M, van der Werf S, Naffakh N. Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J Virol. 2005;79:13811-6.
17. de Wit E, Spronken MI, Vervaet G, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol. 2007;88:1281-7.
18. Neumann G, Fujii K, Kino Y, Kawaoka Y. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A. 2005;102:16825-9.
19. Zhang X, Kong W, Ashraf S, Curtiss III R. A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine. J Virol. 2009;83:9296-303.
20. Chen H, Angel M, Li W, Finch C, Gonzalez AS, Sutton T, et al. All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines. J Virol. 2014;88:10013-25.
21. Neumann G, Kawaoka Y. Reverse genetics of influenza virus. Virology. 2001;287:243-50.
22. Maassab HF, Bryant ML. The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev Med Virol. 1999;9:237-44.
23. Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine. 2005;23:2943-52.
24. Chen Z, Aspelund A, Kemble G, Jin H. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology. 2006;345:416-23.
25. Gerdil C. The annual production cycle for influenza vaccine. Vaccine. 2003;21:1776-9.
26. Jin H, Lu B, Zhou H, Ma C, Zhao J, Yang CF, et al. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology. 2003;306:18-24.
27. Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, Colegate T, et al. Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK. Vaccine. 2009;27:2907-13.
28. Zhang X, Kong W, Wanda SY, Xin W, Alamuri P, Curtiss III R. Generation of influenza virus from avian cells infected by Salmonella carrying the viral genome. PLoS One. 2015;10:e0119041.
29. Kallel H, Diouani MF, Loukil H, Trabelsi K, Snoussi MA, Majoul S, et al. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine. Vaccine. 2006;24:4856-62.
30. Reculard P. Cell-culture vaccines for veterinary use. In: Meslin FX, Kaplan MM, Koprowski H, editors. Laboratory techniques in rabies. 4th ed. Geneva, Switzerland: World Health Organization; 1996. p. 314-23.
31. Kim JY, Kim YG, Lee GM. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol. 2012;93:917-30.
32. Govorkova EA, Matrosovich MN, Tuzikov AB, Bovin NV, Gerdil C, Fanget B, et al. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology. 1999;262:31-8.
33. Merten OW, Manuguerra JC, Hannoun C, van der Werf S. Production of influenza virus in serum-free mammalian cell cultures. Dev Biol Stand. 1999;98:23-37.
34. Almazan F, Galan C, Enjuanes L. The nucleoprotein is required for efficient coronavirus genome replication. J Virol. 2004;78:12683-8.
35. Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis. 2006;194 Suppl 2:S111-8.
36. Kreiss P, Cameron B, Rangara R, Mailhe P, Aguerre-Charriol O, Airiau M, et al. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res. 1999;27:3792-8.
37. Sieben C, Kappel C, Zhu R, Wozniak A, Rankl C, Hinterdorfer P, et al. Influenza virus binds its host cell using multiple dynamic interactions. Proc Natl Acad Sci U S A. 2012;109:13626-31.
38. Monaco L, Marc A, Eon-Duval A, Acerbis G, Distefano G, Lamotte D, et al. Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ. Cytotechnology. 1996;22:197-203.
39. Palese P. Making better influenza virus vaccines? Emerg Infect Dis. 2006;12:61-5.
40. Baz M, Luke CJ, Cheng X, Jin H, Subbarao K. H5N1 vaccines in humans. Virus Res. 2013;178:78-98.
41. Londrigan SL, Turville SG, Tate MD, Deng YM, Brooks AG, Reading PC. N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN. J Virol. 2011;85:2990-3000.
42. Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, et al. The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus. J Virol. 2014;88:1659-72.
43. Lin N, Mascarenhas J, Sealover NR, George HJ, Brooks J, Kayser KJ, et al. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression. Biotechnol Prog. 2015;31:334-46.
44. Song MS, Baek YH, Pascua PN, Kwon HI, Park SJ, Kim EH, et al. Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production. J Gen Virol. 2013;94:1230-5.
45. Suphaphiphat P, Keiner B, Trusheim H, Crotta S, Tuccino AB, Zhang P, et al. Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells. J Virol. 2010;84:3721-5.
46. Laban A, Cohen A. Interplasmidic and intraplasmidic recombination in Escherichia coli K-12. Mol Gen Genet. 1981;184:200-7.
47. Matfield M, Badawi R, Brammar WJ. Rec-dependent and Rec-independent recombination of plasmid-borne duplications in Escherichia coli K12. Mol Gen Genet. 1985;199:518-23.
48. Hartman PS. Transillumination can profoundly reduce transformation frequencies. Biotechniques. 1991;11:747-8.
49. Rand KN. Crystal violet can be used to visualize DNA bands during gel electrophoresis and to improve cloning efficiency. Tech Tips Online. 1996;1:23-4.
50. Zhang X, Wanda SY, Brenneman K, Kong W, Roland K, Curtiss III R. Improving Salmonella vector with rec mutation to stabilize the DNA cargoes. BMC Microbiol. 2011;11:31.